Decent Entry Level Position - Junior Clinical Data Abstractor Tempus AI Employee Review

3.0
Sep 20, 2024
Recommend
CEO approval
Business Outlook

Pros

I worked several different positions within this company and loved the work being done, the atmosphere, and the people running the company. I felt as though the impact of the work was worth dealing with the negative aspects of the job position.

Cons

Data abstraction has a higher turnover rate within the company, which is NOT a bad thing; people tend to move UP (or at the very least equivalent in pay/position] as opposed to leaving the company. The community within the company is lovely; however, the position itself can be quite monotonous, and reading through oncological data can be hard on one's mental health. Just be in a good place mentally for such a position, and understand that the work is essentially data entry.

Explore other reviews about Tempus AI

5.0
Jul 4, 2026
Recommend
CEO approval
Business Outlook

Pros

Good place to work at, very impactful work.

Cons

No cons i can think of tbh.

2.0
Mar 12, 2026
Recommend
CEO approval
Business Outlook

Pros

As mentioned work is great since it is cancer research and my coworkers are amazing. Immediate leadership managers and Sr. managers are good as well but somewhat unorganised. Work life balance is good also and health insurance as long as you get BCBS PPO with copay otherwise you're screwed paying off deductible.

Cons

Pay is below industry average, and there is essentially no room to negotiate a better raise. Employees are actively discouraged from discussing compensation, and whatever leadership decides is final, there are no exceptions. If you try to escalate concerns or request a conversation with senior leadership, such as a senior director or VP, you’ll quickly find yourself getting the runaround. Leadership prefers to hide behind layers of management rather than engage directly. There is also no clear or transparent path for career advancement. Opportunities technically exist, but they are extremely limited. You can do everything right, receive a top rating of 5 on your annual performance review, and still not be promoted to manager or see any meaningful improvement in compensation. To make matters worse, the billionaire CEO and founder has said things like, “Don’t worry about pay because we’re curing cancer.” Statements like that feel incredibly out of touch when employees are earning $50k–$60k a year and receiving annual raises of only about $2,000. On top of that, equity is almost impossible to obtain. You have to fight for even the possibility of it, because stock or equity compensation is reserved almost exclusively for the C-suite and directors, with virtually nothing available for employees below that level.

2
See reviews by: Helpful|Rating|Date|All